Delivery Order SPE2DR25D2006-SPE2DR26F56KH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,189.06 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60 count) under a firm fixed price contract. The order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,232.41 to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count units) on December 2, 2025, with completion scheduled for December 3, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a $29,013.01 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,464.47. This non-set-aside, firm fixed price delivery order is scheduled for completion by December 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established relationship with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count) with a contract value of $2,760.57. This competitive, non-set-aside delivery order was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award utilizes firm fixed-price pricing terms typical of pharmaceutical supply contracts within the...
- The Defense Logistics Agency awarded a delivery order valued at $1,386.21 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units). The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of September 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this order. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $6,675.68. This is a firm fixed-price delivery order executed under a competitive, non-set-aside procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a contract value of $15,777.11. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for ultimate completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $47,329.47 by the Defense Logistics Agency (DLA) on August 21, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 22, 2025. The contract will be performed at the awardee's corporate office location in Conshohocken, PA. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $11,897.40. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement with an ultimate completion date of November 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56KHDelivery Order
The Defense Logistics Agency awarded a $6.82K delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Rifampin 300 mg capsules (60-count). The contract, which carries a firm fixed price and requires completion by December 3, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is performing the work at its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99M through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 12/1/25 |